-
公开(公告)号:US09551694B2
公开(公告)日:2017-01-24
申请号:US13122585
申请日:2009-10-07
Applicant: Karol Lacki
Inventor: Karol Lacki
CPC classification number: B01L3/50255 , B01L3/5085 , B01L2300/069 , G01N30/466 , G01N30/6043 , G01N30/8658 , Y10T436/25
Abstract: A micro titer plate comprising a number of wells filled with separation matrix. According to the invention the volume of the separation matrix is varied between at least some of the wells.
Abstract translation: 包含多个填充有分离基质的孔的微量滴定板。 根据本发明,分离基质的体积在至少一些孔之间变化。
-
公开(公告)号:US09527009B2
公开(公告)日:2016-12-27
申请号:US14252874
申请日:2014-04-15
Applicant: GE HEALTHCARE BIO-SCIENCES AB
Inventor: Klaus Gebauer
CPC classification number: G01N30/6004 , B01D15/18 , B01D15/22 , G01N30/6017 , G01N30/6021 , G01N30/6052 , G01N30/606
Abstract: The present invention relates to axial flow chromatography columns, methods for separating one or more analytes in a liquid by the use of such columns, and systems employing such columns. The column comprises a first port and a second port, the first port and said second port being at essentially the same level or elevation above the level of the bed space on the chromatography column.
Abstract translation: 本发明涉及轴流色谱柱,通过使用这种色谱柱分离液体中的一种或多种分析物的方法,以及采用这种色谱柱的系统。 该柱包括第一端口和第二端口,第一端口和第二端口在色谱柱上的床空间的水平以上基本相同的水平或高度。
-
公开(公告)号:US09522365B2
公开(公告)日:2016-12-20
申请号:US12523323
申请日:2008-02-07
Applicant: Asa Rudstedt , Andreas Axen , Nils Norrman , Anders Larsson
Inventor: Asa Rudstedt , Andreas Axen , Nils Norrman , Anders Larsson
IPC: B01D71/16 , B01J20/26 , B01J20/28 , B01J20/285 , B01J20/286 , B01J20/32 , B01D71/10 , B01D67/00 , B01D61/14 , B01D15/36 , B01D15/38
CPC classification number: B01D71/10 , B01D15/36 , B01D15/3804 , B01D67/0093 , B01D71/16 , B01D2323/30 , B01D2325/14 , B01D2325/16 , B01J20/262 , B01J20/265 , B01J20/267 , B01J20/28033 , B01J20/28085 , B01J20/285 , B01J20/286 , B01J20/3242 , B01J20/3244
Abstract: The invention relates to a process for making porous cross-linked charged cellulosic polymeric membranes capable of binding to a target molecule. The invention provides methods for separating target molecules from other components in a solution comprising use of membranes obtainable by the process of the invention. The method has particular utility in separating proteins and nucleic acids from cell lysates and cultures.
Abstract translation: 本发明涉及一种制备能够结合靶分子的多孔交联带电纤维素聚合物膜的方法。 本发明提供了在包含使用可通过本发明的方法获得的膜的溶液中从目标分子与其它组分分离的方法。 该方法在从细胞裂解物和培养物中分离蛋白质和核酸方面具有特殊的用途。
-
公开(公告)号:US10730908B2
公开(公告)日:2020-08-04
申请号:US15798784
申请日:2017-10-31
Applicant: GE HEALTHCARE BIOPROCESS R&D AB
Inventor: Annika Forss , Mats Ander , Tomas Bjorkman , Hans Blom , Jesper Hansson , Gustav Rodrigo
IPC: C07K1/16 , B01D15/08 , C07K1/22 , C07K16/00 , B01J20/286 , B01J20/285 , B01D15/18 , B01D15/34 , C07K14/31
Abstract: The invention relates to a method of isolating an immunoglobulin, comprising the steps of: a) providing a separation matrix comprising at least 15 mg/ml multimers of immunoglobulin-binding alkali-stabilized Protein A domains covalently coupled to a porous support, wherein the porous support comprises cross-linked polymer particles having a volume-weighted median diameter (d50,v) of 56-70 micrometers and a dry solids weight of 55-80 mg/ml; b) contacting a liquid sample comprising an immunoglobulin with the separation matrix; c) washing the separation matrix with a washing liquid; d) eluting the immunoglobulin from the separation matrix with an elution liquid; and e) cleaning the separation matrix with a cleaning liquid comprising at least 0.5 M NaOH.
-
公开(公告)号:US10208091B2
公开(公告)日:2019-02-19
申请号:US15526849
申请日:2015-12-11
Applicant: GE HEALTHCARE BIOPROCESS R&D AB
Inventor: Gustav Rodrigo , Mats Ander , Tomas Bjorkman
IPC: C07K14/195 , C07K1/22 , C07K16/00
Abstract: A kappa light chain-binding polypeptide comprising or consisting essentially of one or more binding domains of Peptostreptococcus Protein L, each of said domains being selected from the group consisting of domain 2, domain 3 and domain 4.
-
公开(公告)号:US20180327512A1
公开(公告)日:2018-11-15
申请号:US15525688
申请日:2015-11-11
Applicant: GE HEALTHCARE BIOPROCESS R&D AB
Inventor: Gustav Rodrigo , Tomas Bjorkman , Mats Ander
IPC: C07K16/46 , B01J20/289 , B01J20/32 , B01D15/38
CPC classification number: C07K16/46 , B01D15/3809 , B01J20/289 , B01J20/3219 , B01J20/3274 , C07K1/22 , C07K14/31 , C07K16/00 , C07K16/065
Abstract: An Fc-binding polypeptide of improved alkali stability, comprising a mutant of an Fc-binding domain of Staphylococcus Protein A (SpA), as defined by SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO:3, SEQ ID NO: 4, SEQ ID NO: 5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:8, SEQ ID NO 26 or SEQ ID NO 27, wherein at least the alanine residue at the position corresponding to position 42 in SEQ ID NO:4-7 has been mutated to arginine and/or wherein at least the aspartic acid residue at the position corresponding to position 37 in SEQ ID NO:4-7 has been mutated to glutamic acid.
-
公开(公告)号:US20170247407A1
公开(公告)日:2017-08-31
申请号:US15596040
申请日:2017-05-16
Applicant: GE Healthcare BioProcess R&D AB
Inventor: Hans J. Johansson , Ronnie Palmgren
IPC: C07K1/22 , B01D15/38 , B01J20/285 , C07K14/31 , B01J20/289
CPC classification number: C07K1/22 , B01D15/34 , B01D15/3809 , B01J20/285 , B01J20/286 , B01J20/289 , B01J20/3274 , C07K14/245 , C07K14/31 , C07K2319/00
Abstract: The invention discloses a polypeptide capable of binding immunoglobulins or immunoglobulin-containing proteins, which polypeptide comprises six or more domains of protein Z or the C domain of protein A or a functional variant thereof. It also discloses separation matrices comprising the polypeptide and methods of using the separation matrices for separation of immunoglobulins or immunoglobulin-containing proteins.
-
公开(公告)号:US20170182432A1
公开(公告)日:2017-06-29
申请号:US15458667
申请日:2017-03-14
Applicant: GE Healthcare BioProcess R&D AB
Inventor: Klaus Gebauer
CPC classification number: B01D15/206 , B01D15/14 , B01D15/22 , G01N30/56 , G01N30/6021 , G01N30/603 , G01N30/606 , G01N2030/565
Abstract: The invention relates to a method for providing an aseptic chromatography column, said method comprising the steps of: pre-sterilize an empty chromatography column; pre-sterilize a chromatography medium; introducing the pre-sterilized chromatography medium into the pre-sterilized chromatography column using aseptic equipment, thereby providing an aseptic chromatography column comprising chromatography medium.
-
公开(公告)号:US09683013B2
公开(公告)日:2017-06-20
申请号:US13996023
申请日:2011-12-19
Applicant: Tomas Bjorkman , Elin Monie , Gustav Rodrigo
Inventor: Tomas Bjorkman , Elin Monie , Gustav Rodrigo
IPC: B01D15/38 , B01J20/286 , C07K1/22 , B01J20/289 , C07K14/31 , C07K14/745 , B01J20/32
CPC classification number: C07K1/22 , B01D15/3809 , B01J20/286 , B01J20/289 , B01J20/3212 , B01J20/3219 , B01J20/3274 , C07K14/31 , C07K14/745
Abstract: The present invention relates to a method of separating one or more immunoglobulin containing proteins from a liquid. The method includes first contacting the liquid with a separation matrix comprising ligands immobilized to a support; allowing the immunoglobulin containing proteins to adsorb to the matrix by interaction with the ligands; followed by an optional step of washing the matrix containing the immunoglobulin containing proteins adsorbed thereon; and recovering said immunoglobulin containing proteins by contacting the matrix with an eluent which releases the proteins. The method improves upon previous separation methods in that each of the ligands comprises one or more of a protein A domain (E, D, A, B, C), or protein Z, or a functional variant thereof, with at least one of the monomers having a substitution of the Asparagine at the position corresponding to N28 of B domain of Protein A or Protein Z, and wherein the ligand provides an increase in elution pH compared to non-substituted ligand.
-
公开(公告)号:US09624262B2
公开(公告)日:2017-04-18
申请号:US14345302
申请日:2012-09-14
Applicant: James Van Alstine , Mikael Berg , Johanna Kjorning , Jamil Shanagar
Inventor: James Van Alstine , Mikael Berg , Johanna Kjorning , Jamil Shanagar
Abstract: There is a recognized need for novel, more simplified, approaches to isolation of plasma from whole blood, as well as a need to isolate cell-free plasma fractions containing different plasma proteins. Methods are divulged for use of aqueous phase systems, formed in blood or blood containing solutions via addition of a single polymer at relatively low concentration, to effect isolation (clarification) of plasma proteins from blood cells. Methods are also divulged to replace widely used Cohn-type plasma protein fractionation which is based on sequential addition of up to 40% (v/v) ethanol and other precipitants, with simple sequential addition of a polyacid. The latter results in isolation of plasma protein fractions (i.e. fibrinogen, immunoglobulin, albumin) in sequence similar to that obtained with Cohn Fractionation and therefore may be suitable for use to reduce solvent use and solvent-related process complications in existing plasma protein purification processes. It may also support use of polymeric film based containers in novel solvent free plasma fractionation processes. The methods disclosed may also be suitable for use in smaller scale plasma protein isolation, in research and diagnostic applications. The general methodologies are robust and can function over a broad range of process variables such as temperature and pH.
-
-
-
-
-
-
-
-
-